NASDAQ:ITRM
Iterum Therapeutics plc
- Stock
Last Close
1.13
30/08 20:00
Market Cap
24.34M
Beta: 1.61
Volume Today
236.11K
Avg: 63.45K
PE Ratio
−0.61
PFCF: −0.64
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | -13.46M - | -29.41M 118.40% | -77.06M 162.04% | -103.13M 33.84% | -52.01M 49.57% | -91.56M 76.06% | -44.43M 51.47% | ||
depreciation and amortization | 65K - | 136K 109.23% | 152K 11.76% | 161K 5.92% | 2.10M 1,206.83% | 1.80M 14.45% | |||
deferred income tax | 44K - | -701K 1,693.18% | -125K 82.17% | 1.41M 1,224% | 61.60M 4,284.34% | ||||
stock based compensation | 348K - | 392K 12.64% | 1.29M 229.08% | 2.17M 68.45% | 2.76M 26.97% | 4.32M 56.54% | 4.76M 10.16% | ||
change in working capital | 1.82M - | -1.60M 188.23% | -1.60M 0.06% | 17.90M 1,216.59% | -24.56M 237.19% | -440K 98.21% | 2.31M 625.23% | ||
accounts receivables | |||||||||
inventory | |||||||||
accounts payables | 1.19M - | 1.67M 40.66% | 849K 49.19% | 11.45M 1,248.17% | -14.67M 228.18% | 63K 100.43% | 1.90M 2,907.94% | ||
other working capital | 630K - | -3.27M 619.84% | -2.45M 25.13% | 6.45M 363.17% | -9.88M 253.18% | -503K 94.91% | 416K 182.70% | ||
other non cash items | -95K - | 2.04M 2,251.58% | 4.15M 102.84% | 17.71M 327.13% | 8.14M 54.04% | 17.09M 110.00% | |||
net cash provided by operating activities | -11.30M - | -30.60M 170.88% | -75.89M 147.97% | -78.89M 3.95% | -54.53M 30.88% | -15.84M 70.95% | -18.47M 16.61% | -39.33M 112.91% | |
investments in property plant and equipment | -812K - | -90K 88.92% | -24K 73.33% | -11K 54.17% | -61K 454.55% | -62K 1.64% | |||
acquisitions net | 54.53K - | -14.02K 125.71% | |||||||
purchases of investments | -53.27M - | -96.49M 81.12% | -67.03M - | -45.71M 31.81% | |||||
sales maturities of investments | 22.50M - | 87.92M 290.78% | 40.13M 54.36% | 12.50M - | 59.73M 377.82% | ||||
other investing activites | -54.53K - | 14.02K 125.71% | 23.34M 166,359.80% | ||||||
net cash used for investing activites | -31.59M - | -8.66M 72.59% | 40.10M 563.17% | -11K 100.03% | -54.59M 496,218.18% | 13.96M 125.56% | 23.34M 67.20% | ||
debt repayment | -1.03M - | -6.23M 502.80% | -6.52M 4.54% | -2.25M 65.45% | |||||
common stock issued | 74.15M - | 60K 99.92% | 69.96M 116,506.67% | 89.64M 28.13% | 433K 99.52% | ||||
common stock repurchased | |||||||||
dividends paid | |||||||||
other financing activites | 20.85M - | 45.87M 119.98% | 46.69M 1.79% | 2.06K 100.00% | 744K 35,963.98% | 1.03M - | |||
net cash used provided by financing activities | 20.85M - | 45.87M 119.98% | 120.84M 163.46% | -974K 100.81% | 64.47M 6,719.61% | 83.13M 28.93% | -1.82M 102.19% | 1.03M 156.88% | |
effect of forex changes on cash | -108K - | -22K 79.63% | -11K 50% | 4K 136.36% | -50K 1,350% | -61K 22% | |||
net change in cash | 9.55M - | -16.32M 270.88% | 36.19M 321.67% | -39.78M 209.93% | 9.93M 124.95% | 12.69M 27.90% | -6.38M 150.29% | -15.02M 135.29% | |
cash at beginning of period | 15.26M - | 24.81M 62.62% | 8.48M 65.80% | 44.67M 426.47% | 4.89M 89.05% | 14.82M 202.92% | 27.51M 85.68% | ||
cash at end of period | 24.81M - | 8.48M 65.80% | 44.67M 426.47% | 4.89M 89.05% | 14.82M 202.92% | 27.51M 85.68% | 21.13M 23.21% | -15.02M 171.10% | |
operating cash flow | -11.30M - | -30.60M 170.88% | -75.89M 147.97% | -78.89M 3.95% | -54.53M 30.88% | -15.84M 70.95% | -18.47M 16.61% | -39.33M 112.91% | |
capital expenditure | -812K - | -90K 88.92% | -24K 73.33% | -11K 54.17% | -61K 454.55% | -62K 1.64% | |||
free cash flow | -11.30M - | -31.42M 178.07% | -75.98M 141.85% | -78.91M 3.85% | -54.54M 30.88% | -15.90M 70.84% | -18.54M 16.55% | -39.33M 112.19% |
All numbers in USD (except ratios and percentages)